| Pharmaceutical Drugs & Formulations | Manufacture and sale of tablets, capsules, injectables, ointments, syrups, and herbal medicines | Strong manufacturing infrastructure, diversified product range, established export markets | B2B and B2C serving healthcare providers, retailers, and consumers | Herbal products and specialized injectables | 470 | 94 | Product sales to wholesalers, hospitals, pharmacies, and export clients | Direct sales with volume-based pricing; negotiated contracts for bulk buyers | Rising chronic disease demand, export market growth, capacity expansion | Edicare, Attom Megacaps, Ecziguard, Yas Antacid |
| Trading of Commodities | Trading of pharmaceutical raw materials and commodities | Industry relationships and sourcing capabilities | B2B clients in pharma manufacturing | | 8 | 2 | Trading margins and commissions | Standard trading based on market prices | Procurement efficiencies and market demand | |
| Renting of Property | Leasing of company-owned properties | Strategic property locations and long-term leases | Corporate tenants and other businesses | | 4 | 1 | Rental income | Fixed lease contracts | Real estate asset utilization | |
